Skip to content

Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome

Retrobulbar Injection of Anesthesia Versus Injection of Healon 5 Viscoelastic Into the Anterior Chamber in the Management of Intraoperative Floppy Iris Syndrome

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00627913
Enrollment
6
Registered
2008-03-04
Start date
2008-02-29
Completion date
2010-11-11
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Floppy Iris Syndrome

Keywords

Floppy Iris Syndrome

Brief summary

In this study, the investigators plan to compare the incidence and complications of intraoperative floppy iris syndrome (IFIS) during cataract surgery in patients taking tamsulosin (Flomax) and treated with retrobulbar injection of anesthesia, versus injection of Healon 5 viscoelastic into the anterior chamber.

Interventions

PROCEDUREHealon 5 injection

Healon 5 (2.3% Sodium hyaluronate) ophthalmic viscoelastic device will be injected into the anterior chamber as needed for pupillary dilation and adequate cataract extraction with intraocular lens placement.

PROCEDURERetrobulbar anesthetic injection

3-4cc of anesthetic (1% lidocaine/0.75% bupivicaine) will be injected with a 25 gauge needle into the extraocular muscle cone prior to patient and microscope positioning. Cataract extraction with intraocular lens placement will then proceed in standard fashion.

Sponsors

Penn State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* All cataract patients taking tamsulosin

Exclusion criteria

* Patients with any history of iridocyclitis * Presence of iris neovascularization * History of prior iris surgery * Presence of traumatic cataracts * Presence of zonular dialysis

Design outcomes

Primary

MeasureTime frame
Pupil diameter after hydrodissection2 years

Secondary

MeasureTime frame
Pupil diameter after nuclear removal2 years
Pupil diameter after cortex removal2 years
Pupil diameter at conclusion of surgery2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026